{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:19:09Z","timestamp":1789967949027,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T00:00:00Z","timestamp":1296691200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2407-11-55","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T19:15:46Z","timestamp":1299093346000},"source":"Crossref","is-referenced-by-count":10,"title":["Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma"],"prefix":"10.1186","volume":"11","author":[{"given":"Maria G","family":"Zampino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Petazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Trovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Nol\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,3]]},"reference":[{"issue":"10","key":"2555_CR1","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","volume":"51","author":"ND Nigro","year":"1983","unstructured":"Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ: Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer. 1983, 51 (10): 1826-9. 10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L.","journal-title":"Cancer"},{"key":"2555_CR2","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized Intergroup study. J Clin Oncol. 1996, 14: 2527-2539.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2555_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1072-7515(97)00094-X","volume":"185","author":"PR Fuchshuber","year":"1997","unstructured":"Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ: Anal canal and perianal epidermoid cancers. J Am Coll Surg. 1997, 185 (5): 494-505.","journal-title":"J Am Coll Surg"},{"key":"2555_CR4","first-page":"48","volume-title":"World Health Organization Offset Publication","author":"Geneva (Switzerland)","year":"1979","unstructured":"Geneva (Switzerland): WHO handbook for reporting results of cancer treatment. World Health Organization Offset Publication. 1979, 48-"},{"key":"2555_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","volume":"22","author":"EB Wilson","year":"1972","unstructured":"Wilson EB: Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1972, 22: 209-212. 10.2307\/2276774.","journal-title":"J Am Stat Assoc"},{"key":"2555_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/A:1011107105538","volume":"12","author":"D Peiffert","year":"2001","unstructured":"Peiffert D, Giovannini M, Ducreux M, Michel P, Francois E, Lemanski C, Mirabel X, Cvitkovic F, Luporsi E, Conroy T, G\u00e9rard JP, Digestive Tumours Group of the French 'F\u00e9d\u00e9ration Nationale des Centres de Lutte Contre le Cancer': High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal carcinoma: Final results of a phase II study. Ann Oncol. 2001, 12: 397-404. 10.1023\/A:1011107105538.","journal-title":"Ann Oncol"},{"key":"2555_CR7","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, Thomas CR, Mayer RJ, Haddock MG, Rich TA, Willet C: Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA. 2008, 299: 1914-1921. 10.1001\/jama.299.16.1914.","journal-title":"JAMA"},{"key":"2555_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"UKCCCR Anal Cancer Working Party","year":"1996","unstructured":"UKCCCR Anal Cancer Working Party: Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin c. Lancet. 1996, 348: 1049-1054. 10.1016\/S0140-6736(96)03409-5.","journal-title":"Lancet"},{"key":"2555_CR9","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997, 15: 2040-2049.","journal-title":"J Clin Oncol"},{"key":"2555_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/0360-3016(96)00146-0","volume":"35","author":"S Martenson","year":"1996","unstructured":"Martenson S, Lipsitz H, Wagner Kaplan EH, Otteman LA, Schunther LM: Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys. 1996, 35: 745-749. 10.1016\/0360-3016(96)00146-0.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2555_CR11","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.1996.14.12.3121","volume":"14","author":"R Doci","year":"1996","unstructured":"Doci R, Zucali R, La Monica G, Meroni E, Kenda R, Eboli M, Lozza L: Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol. 1996, 14: 3121-5.","journal-title":"J Clin Oncol"},{"key":"2555_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0167-8140(97)00192-8","volume":"46","author":"JP Gerard","year":"1998","unstructured":"Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet J, Mornex F: Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatin. Long-term results in 95 patients. Radiother Oncol. 1998, 46: 249-256. 10.1016\/S0167-8140(97)00192-8.","journal-title":"Radiother Oncol"},{"key":"2555_CR13","first-page":"8:8","volume":"15","author":"BC Cho","year":"2008","unstructured":"Cho BC, Ahn JB, Seong J, Roh JK, Kim JH, Chung HC, Sohn JH, Kim NK: Chemoradiotherapy with or without consolidation chemotherapy using Cisplatin and 5-Fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients. BMC Cancer. 2008, 15: 8:8-","journal-title":"BMC Cancer"},{"key":"2555_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","volume":"50","author":"DC Weber","year":"2001","unstructured":"Weber DC, Kurtz JM, Allal AS: The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys. 2001, 50: 675-680. 10.1016\/S0360-3016(01)01510-3.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2555_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0167-8140(01)00404-2","volume":"61","author":"RJ Myerson","year":"2001","unstructured":"Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ, Picus J, Ratkin GA, Read TE, Walz BJ: Radiation therapy for epidermoid carcinoma of the anal canal clinical and treatment factors associated with outcome. Radiother Oncol. 2001, 61: 15-22. 10.1016\/S0167-8140(01)00404-2. 2001","journal-title":"Radiother Oncol"},{"key":"2555_CR16","first-page":"201","volume":"24","author":"SV Deo","year":"2005","unstructured":"Deo SV, Shukla NK, Raina V, Mohanti BK, Sharan R, Kar M, Rath GK: Organ-preserving multimodality management of squamous cell carcinoma of anal canal. Int J Gastroenter. 2005, 24: 201-204.","journal-title":"Int J Gastroenter"},{"key":"2555_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0360-3016(03)00016-6","volume":"56","author":"T Vuong","year":"2003","unstructured":"Vuong T, Devic S, Belliveau P, Muanza T, Hegyi G: Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study. Int J Radiat Oncol Biol Phys. 2003, 56: 823-831. 10.1016\/S0360-3016(03)00016-6.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2555_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.clon.2005.03.008","volume":"17","author":"R James","year":"2005","unstructured":"James R, Meadows H, Wan S: ACT II: The second UK phase III anal cancer trial. Clin Oncol (R Coll Radiol). 2005, 17: 364-366.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2555_CR19","first-page":"172","volume":"2","author":"D Peiffert","year":"2005","unstructured":"Peiffert D, Gerard JP, Ducreux M, Lemanski C, Fran\u00e7ois E, Giovannini Cvitkovic F, Mirabel X, Bouch\u00e8 O, Luporsi E: Induction chemotherapy (ICT) and dose intensification of the radiation boost in locally advanced anal cancer (LAACC): Interim analysis of the 101 first randomized patients (pts) in the Intergroup ACCORD 03 trial (Federation Nacionale des Centres de Lutte Contre le Cancer - Fondation Francaise de Cancerologie Digestive). Eur J Cancer. 2005, 2: 172-(suppl 3; abstr 614)","journal-title":"Eur J Cancer"},{"key":"2555_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.radonc.2007.12.004","volume":"87","author":"L Tournier-Rangeard","year":"2008","unstructured":"Tournier-Rangeard L, Mercier M, Peiffert D, Gerard JP, Romestaing P, Lemanski C, Mirabel X, Pommier P, Denis B: Radiochemotherapy of locally advanced anal canal carcinoma: Prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol. 2008, 87: 391-397. 10.1016\/j.radonc.2007.12.004.","journal-title":"Radiother Oncol"},{"issue":"16","key":"2555_CR21","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.ejca.2009.06.020","volume":"45","author":"O Matzinger","year":"2009","unstructured":"Matzinger O, Roelofsen F, Mineur L, Koswig S, Van Der Steen-Banasik EM, Van Houtte P, Haustermans K, Radosevic-Jelic L, Mueller RP, Maingon P, Collette L, Bosset JF, For the EORTC Radiation Oncology and Gastrointestinal Tract Cancer Groups: Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014). Eur J Cancer. 2009, 45 (16): 2782-91. 10.1016\/j.ejca.2009.06.020.","journal-title":"Eur J Cancer"},{"key":"2555_CR22","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1200\/JCO.2008.18.1651","volume":"26","author":"R Glynne-Jones","year":"2008","unstructured":"Glynne-Jones R, Mawdsley S: Anal cancer: the end of the road for neoadjuvant chemoradiotherapy?. J Clin Oncol. 2008, 26: 3669-3671. 10.1200\/JCO.2008.18.1651.","journal-title":"J Clin Oncol"},{"key":"2555_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.radonc.2008.04.011","volume":"87","author":"K Saarilahti","year":"2008","unstructured":"Saarilahti K, Arponen P, Vaalarvirta L, Tenhunen M: The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer. Radiother Onco l. 2008, 87: 383-390. 10.1016\/j.radonc.2008.04.011.","journal-title":"Radiother Onco l"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-11-55\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-11-55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T20:25:50Z","timestamp":1497903950000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-11-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2555"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-11-55","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,3]]},"article-number":"55"}}